Guest Open Access Plus | Free Content | About | Sign in | New Users: Sign up | Mark List  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents)

Volume 9 Issue 3
ISSN: 1871-5257
eISSN: 1875-6182

 

   All Titles

  Up-Regulation of the Cardiac Lipid Metabolism at the Onset of Heart Failure
  pp.190-206 (17) Authors: Said AbdAlla, Xuebin Fu, Sherif S. Elzahwy, Kristin Klaetschke, Thomas Streichert, Ursula Quitterer
 
 
      Abstract

Chronic pressure overload and atherosclerosis are primary etiologic factors for cardiac hypertrophy and failure. However, mechanisms underlying the transition from hypertrophy to heart failure are incompletely understood. We analyzed the development of heart failure in mice with chronic pressure overload induced by aortic constriction and compared the results with aged apolipoprotein E-deficient mice suffering from advanced atherosclerosis. We combined cardiac function analysis by echocardiography and invasive hemodynamics with a comprehensive microarray gene expression study (GSE25765-8). The microarray data showed that the onset of heart failure induced by pressure overload or advanced atherosclerosis was accompanied by a strong up-regulation of key lipid metabolizing enzymes involved in fat synthesis, storage and oxidation. Cardiac lipid overload may be involved in the progression of heart failure by enhancing cardiomyocyte death. Up-regulation of the cardiac lipid metabolism was related to oxygen and ATP depletion of failing hearts because anti-ischemic treatment with ranolazine normalized the cardiac lipid metabolism and improved cardiac function. Vice versa, inhibition of cellular respiration and ATP generation by mild thiol-blocking with cystamine triggered the cardiac lipid metabolism and caused signs of heart failure. Cardiac tissue specimens of patients with heart failure also showed high protein levels of key fat metabolizing enzymes as well as lipid accumulation. Taken together, our data strongly indicate that up-regulation of the cardiac lipid metabolism and myocardial lipid overload are underlying the development of heart failure.

 
  Keywords: Aortic constriction, atherosclerosis, heart failure, lipid metabolism, microarray gene expression analysis, pressure, overload, ranolazine
  Affiliation: Molecular Pharmacology Unit, Swiss Federal Institute of Technology Zurich, Room Y17M70, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
 
  Key: New Content Free Content Open Access Plus Subscribed Content

Bentham Science Publishers
www.benthamscience.com

 

  Copyright © 1994 - 2014   Bentham Science Publishers